論文

査読有り 最終著者 責任著者 本文へのリンクあり 国際誌
2022年3月

Expression of a PYCARD/ASC variant lacking exon 2 in Japanese patients with palindromic rheumatism increases interleukin-1β secretion

Asian Pacific Journal of Allergy and Immunology
  • Yumi Suganuma , Hayate Tanaka , Aya Kawase , Aoi Kishida , Moeko Yamaguchi , Atsuko Yabuuchi , Koji Inoue , Shunichi Shiozawa and Koichiro Komai

40
1
開始ページ
81
終了ページ
86
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.12932/ap-040319-0509
出版者・発行元
Allergy, Asthma, and Immunology Association of Thailand

BACKGROUND: Palindromic rheumatism (PR) is a rare periodic arthritis characterized by relapsing short episodes of arthritis. Although the pathogenesis of PR is still unclear, the clinical condition is similar to that of autoinflammatory diseases caused by dysregulation of inflammasome-related genes. OBJECTIVE: We analyzed the inflammasome adapter PYD and CARD domain-containing protein/apoptosis-associated speck-like protein containing a CARD (PYCARD/ASC) in Japanese patients with PR. METHODS: Serum interleukin (IL)-1β concentrations in three Japanese patients with PR were measured. We also cloned PYCARD/ASC cDNA variants and expressed them in THP-1 cells to determine their effects on inflammasome activity following stimulation with phorbol 12-myristate 13-acetate and monosodium urate. Lysates of recombinant THP-1 cells were subjected to co-immunoprecipitation assays. RESULTS: Serum IL-1β concentrations were significantly elevated in patients with PR, and a splice variant of PYCARD/ ASC mRNA lacking exon 2 (Δexon2) was dominantly expressed compared with that in controls. Moreover, IL-1β secretion was significantly increased in THP-1 cells expressing Δexon2PYCARD/ASC compared with that in cells expressing the wild-type protein. The amount of NLRP3 bound to Δexon2PYCARD/ASC was increased after stimulation, whereas that bound to the wild-type protein was decreased. There were no differences in caspase-1 binding. CONCLUSIONS: Δexon2 PYCARD/ASC was associated with the pathogenesis of PR.

リンク情報
DOI
https://doi.org/10.12932/ap-040319-0509 本文へのリンクあり
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31421660
共同研究・競争的資金等の研究課題
インフラマソーム機能変調疾患における汎用新規バイオマーカーの開発
ID情報
  • DOI : 10.12932/ap-040319-0509
  • ISSN : 0125-877X
  • eISSN : 2228-8694
  • PubMed ID : 31421660

エクスポート
BibTeX RIS